MINERAL OIL AND PETROLATUM

MINERAL OIL AND PETROLATUM was reported 14 times

MINERAL OIL AND PETROLATUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXPOSURE KERATITIS 1 0.0333
1 PRODUCT STERILITY LACKING 1 0.0119
2 DEPOSIT EYE 3 0.0112
3 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 1 0.0095
4 CORNEAL OPACITY 2 0.0015
5 CORNEAL DEPOSITS 1 0.0013
6 DARK CIRCLES UNDER EYES 1 0.0007
7 EYELID PAIN 1 0.0005
8 HORDEOLUM 2 0.0005
9 PRODUCT RESIDUE PRESENT 2 0.0004
10 INFUSION SITE REACTION 1 0.0003
11 FACET JOINT SYNDROME 1 0.0003
12 PERIPHERAL VENOUS DISEASE 1 0.0002
13 ONYCHOMADESIS 1 0.0002
14 ONYCHOMYCOSIS 1 0.0002
15 RHEUMATIC FEVER 1 0.0002
16 FINGER DEFORMITY 1 0.0002
17 NORMAL NEWBORN 1 0.0002
18 RHEUMATOID FACTOR POSITIVE 1 0.0002
19 PRODUCT LABEL CONFUSION 1 0.0002
20 BLEPHAROSPASM 1 0.0002
21 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
22 BREAST CANCER STAGE III 1 0.0002
23 SKIN MASS 1 0.0001
24 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
25 DUODENAL ULCER PERFORATION 1 0.0001
26 MUSCLE INJURY 1 0.0001
27 LIVE BIRTH 1 0.0001
28 NAIL DISORDER 1 0.0001
29 GRIP STRENGTH DECREASED 1 0.0001
30 LUPUS-LIKE SYNDROME 1 0.0001
31 LIP DRY 1 0.0001
32 EXOSTOSIS 1 0.0001
33 RECALLED PRODUCT ADMINISTERED 1 0.0001
34 HYPERCHOLESTEROLAEMIA 1 0.0001
35 COELIAC DISEASE 1 0.0001
36 HELICOBACTER INFECTION 1 0.0001
37 FOLLICULITIS 1 0.0001
38 BACK INJURY 1 0.0001
39 WOUND INFECTION 1 0.0001
40 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
41 EYE INFECTION 1 0.0001
42 BURSITIS 1 0.0001
43 PEMPHIGUS 1 0.0001
44 HAND DEFORMITY 1 0.0001
45 ADVERSE REACTION 1 0.0001
46 JOINT RANGE OF MOTION DECREASED 1 0.0001
47 OBESITY 1 0.0001
48 SCIATICA 1 0.0001
49 SENSORY DISTURBANCE 1 0.0001
50 FUNGAL INFECTION 2 0.0001
51 PERICARDITIS 1 0.0001
52 SYNOVITIS 1 0.0001
53 HEPATIC CIRRHOSIS 1 0.0001
54 PULMONARY FIBROSIS 1 0.0001
55 LOWER LIMB FRACTURE 1 0.0001
56 TASTE DISORDER 1 0.0000
57 IRRITABLE BOWEL SYNDROME 1 0.0000
58 LIVER FUNCTION TEST INCREASED 1 0.0000
59 PRURITUS GENERALISED 1 0.0000
60 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
61 GLOSSODYNIA 1 0.0000
62 OCULAR HYPERAEMIA 2 0.0000
63 FIBROMYALGIA 1 0.0000
64 LIVER INJURY 1 0.0000
65 AGEUSIA 1 0.0000
66 HEPATITIS 1 0.0000
67 MUSCULOSKELETAL PAIN 2 0.0000
68 JOINT STIFFNESS 1 0.0000
69 WOUND 1 0.0000
70 EYE PAIN 2 0.0000
71 EYE IRRITATION 2 0.0000
72 RESPIRATORY DISORDER 1 0.0000
73 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
74 EPILEPSY 1 0.0000
75 DRUG-INDUCED LIVER INJURY 1 0.0000
76 NIGHT SWEATS 1 0.0000
77 IMPAIRED HEALING 1 0.0000
78 GAIT INABILITY 1 0.0000
79 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
80 C-REACTIVE PROTEIN INCREASED 1 0.0000
81 EYE SWELLING 1 0.0000
82 PSORIATIC ARTHROPATHY 1 0.0000
83 BLINDNESS 1 0.0000
84 OSTEOARTHRITIS 1 0.0000
85 LIVER DISORDER 1 0.0000
86 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
87 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
88 BLOOD CHOLESTEROL INCREASED 1 0.0000
89 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
90 LUNG DISORDER 1 0.0000
91 INFLAMMATION 1 0.0000
92 OEDEMA 1 0.0000
93 ARTHROPATHY 1 0.0000
94 NECK PAIN 1 0.0000
95 BLISTER 1 0.0000
96 WHEEZING 1 0.0000
97 STOMATITIS 1 0.0000
98 ILL-DEFINED DISORDER 1 0.0000
99 VISUAL IMPAIRMENT 2 0.0000
100 EXPOSURE DURING PREGNANCY 1 0.0000
101 INFUSION RELATED REACTION 1 0.0000
102 HEPATIC ENZYME INCREASED 1 0.0000
103 INJECTION SITE REACTION 1 0.0000
104 INJURY 1 0.0000
105 SLEEP DISORDER 1 0.0000
106 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
107 MOBILITY DECREASED 1 0.0000
108 INFECTION 2 0.0000
109 UNDERDOSE 1 0.0000
110 WEIGHT INCREASED 3 0.0000
111 HYPOAESTHESIA 2 0.0000
112 PERIPHERAL SWELLING 2 0.0000
113 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
114 DRY MOUTH 1 0.0000
115 TREATMENT FAILURE 1 0.0000
116 SKIN EXFOLIATION 1 0.0000
117 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
118 MUSCULOSKELETAL STIFFNESS 1 0.0000
119 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
120 GASTROINTESTINAL DISORDER 1 0.0000
121 ADVERSE EVENT 1 0.0000
122 SWELLING 1 0.0000
123 MIGRAINE 1 0.0000
124 DYSPEPSIA 1 0.0000
125 SINUSITIS 1 0.0000
126 ABDOMINAL DISTENSION 1 0.0000
127 RHEUMATOID ARTHRITIS 1 0.0000
128 MUSCULAR WEAKNESS 1 0.0000
129 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
130 JOINT SWELLING 1 0.0000
131 MEMORY IMPAIRMENT 1 0.0000
132 RASH 3 0.0000
133 CONFUSIONAL STATE 1 0.0000
134 URTICARIA 1 0.0000
135 URINARY TRACT INFECTION 1 0.0000
136 MUSCLE SPASMS 1 0.0000
137 NASOPHARYNGITIS 1 0.0000
138 HYPERSENSITIVITY 1 0.0000
139 PRODUCT USE ISSUE 1 0.0000
140 GAIT DISTURBANCE 1 0.0000
141 ALOPECIA 1 0.0000
142 ARTHRALGIA 2 0.0000
143 HYPERTENSION 1 0.0000
144 OVERDOSE 1 0.0000
145 DEPRESSION 1 0.0000
146 BACK PAIN 1 0.0000
147 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
148 INSOMNIA 1 0.0000
149 PAIN IN EXTREMITY 1 0.0000
150 CONDITION AGGRAVATED 1 0.0000
151 DIARRHOEA 2 0.0000
152 PNEUMONIA 1 0.0000
153 FALL 1 0.0000
154 PYREXIA 1 0.0000
155 ASTHENIA 1 0.0000
156 OFF LABEL USE 2 0.0000
157 MALAISE 1 0.0000
158 VOMITING 1 0.0000
159 DIZZINESS 1 0.0000
160 DYSPNOEA 1 0.0000
161 HEADACHE 1 0.0000
162 DRUG INEFFECTIVE 2 0.0000
163 FATIGUE 1 0.0000
164 NAUSEA 1 0.0000